ShadowBuys
Sign inJoin for free

Rep. Josh Gottheimer sold Alnylam Pharmaceuticals (ALNY)

Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Dec 11, 2023

Transaction
Sold
Amount
$1K–$15K
Owner
Joint
Traded
Dec 11, 2023
Disclosed
Jan 7, 2024
Days to disclose
27
Asset type
Stock
As filed
Alnylam Pharmaceuticals, Inc.
Industry
Biotechnology · Healthcare
Official filing ↗All of Gottheimer's tradesAll Congress trades in ALNY

Other trades in this filing

All of Gottheimer's trades →

Recent Congress trades in ALNY

Company context for ALNY

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. ALNYCompany announcement·SEC EDGAR

    ALNY: Leadership change · Other company developments

    Filed 8-K for an event or period dated 2026-11-02. Leadership change; Other company developments.

    Public: Nov 5, 2026, 7:37 AM ESTEvent / period: Nov 2, 2026Original source ↗
  2. ALNYFinancial report·SEC EDGAR

    ALNY: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 29, 2026, 8:20 AM EDTEvent / period: Sep 30, 2026Original source ↗
  3. ALNYCompany announcement·SEC EDGAR

    ALNY: Financial results

    Filed 8-K for an event or period dated 2026-10-29. Financial results.

    Public: Oct 29, 2026, 8:16 AM EDTEvent / period: Oct 29, 2026Original source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.